Oncology, answered.
ESMO AI & Digital Oncology Congress 2026
November 16-17, 2026
Berlin, Germany
2 research acceptances
From data to decisions, at every phase of development.
Flatiron combines real-world data with deep scientific and clinical expertise to deliver insights that data or AI alone cannot. AI accelerates analysis and scales discovery but rigorous methodology, clinical validation, and human judgment remain essential. We're applying this approach through predictive modeling, digital twins, and Flatiron Telescope, tools designed to answer your toughest research questions.
Featured speaking session
Predictive Modeling's Next Frontier in Oncology Drug Development
Date: Monday, November 16
Time: 11:45–12:05
Location: Central stage in the exhibition area
Oncology leaders face increasing pressure to move faster, without taking on more risks. Digital twins and predictive models offer new ways to inform critical drug development decisions. With the growing scale, depth and quality of data collected as part of routine care, real-world data are being increasingly used to develop predictive models.
This talk explores how digital twins and predictive models can power oncology drug development to accelerate timeline and improve probability of success.
speakers
Jessica Davies
Scientific Director, Clinical Development Solutions